This inventor holds 10 USPTO granted patents and 21 published patent applications and 1 EPO patent. Top assignee: Other. Active years: 2014-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2024
Title: Innovator Profile: Artur Viktorovich Martynov - Pioneering Solutions in Antiviral Biotechnology
Introduction:
Meet Artur Viktorovich Martynov, a prominent innovator from Kharkiv, Ukraine, who has made significant contributions in the field of biotechnology. With an impressive portfolio of nine patents, Martynov's latest inventions focus on developing groundbreaking formulations with immunomodulatory and protective antiviral effects. His pioneering work has the potential to revolutionize the food, cosmetic, and pharmaceutical industries, offering new ways to prevent and treat diseases associated with immunodeficiencies and respiratory viral infections.
Food, Cosmetic, and Pharmaceutical Formulation:
Martynov's recent patent proudly addresses the urgent need for effective antiviral solutions. The invention centers around a unique composition with immunomodulating and protective antiviral properties that can be incorporated into various products across multiple industries. Notably, this formulation boasts complete prevention against a range of viruses, including influenza, rotavirus, and even coronavirus. Additionally, it surpasses the immune-stimulating capabilities of individual probiotics. With potential applications in medicine, food production, and cosmetology, Martynov's work opens new doors for proactive disease prevention and treatment.
Combinatorial Derivatives of Oligopeptides:
In another significant breakthrough, Martynov introduces a novel approach to combating viral diseases such as influenza and herpes virus infections. His patent revolves around the synthesis of combinatorial derivatives of oligopeptides with potent antiviral properties. These compounds, when used as a whole without separation into individual components, demonstrate exceptional antiviral efficacy. By developing these libraries of derivatives and their supramolecular structures, Martynov paves the way for more efficient treatment methods that could potentially reduce the duration of illnesses.
Collaborators: Boris Farber and Sof'ya Farber:
Martynov has been fortunate to collaborate with fellow innovators Boris Farber and Sof'ya Farber in his groundbreaking research. This partnership has likely facilitated the exchange of knowledge, insights, and resources, enabling them to collectively advance their innovative ideas in the biotechnology field.
Conclusion:
Artur Viktorovich Martynov's remarkable work in the biotechnology sector has produced a series of patented inventions that promise to revolutionize disease prevention and treatment. With patents spanning various industries and fields, Martynov's formulations provide potent immunomodulatory and antiviral effects, helping combat diseases associated with immunodeficiencies and respiratory infections. Martynov's collaborations with Boris Farber and Sof'ya Farber further illustrate the power of innovative teamwork in advancing scientific breakthroughs. As we eagerly await the practical implementation of these patented inventions, we can anticipate significant improvements in the way we tackle viral diseases and safeguard global health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile